RETRACTED: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways
PLOS ONE · 08.01.2025 · 20 (1) · e0310852
DOI: 10.1371/journal.pone.0310852 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift PLOS ONE, online erschienen am 08.01.2025. Verfasst von Binmei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Transforming Growth Factor beta1, Fibrosis, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Projects of Fourth Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
Atrial fibrillation (AF) represents the commonly occurring cardiac arrhythmia and the main factor leading to stroke and heart failure. Hydrogen (H 2 ) is a gaseous signaling molecule that has the effects of anti-inflammation and antioxidation. Our study provides evidence that hydrogen decreases susceptibility to AngII-mediated AF together with atrial fibrosis. Following continuous AngII administration for a 28-day period, AngII+H 2 treated rats showed decreased susceptibility to AF, a decrease in atrial fibrosis, a decrease in ROS in atrial myocytes, an inhibition of NLRP3 inflammasome activation, an improvement in electrical remodeling, and an inhibition of proliferation and migration of cardiac fibroblasts. We further found that hydrogen regulates the activation of inflammasome and thus improves Ca 2+ handling and IKAch and IKur by inhibiting the activity of NOX4 in vivo. In addition, hydrogen was involved in AngII-mediated atrial fibrosis through inhibiting TGF-β1/Smad2/3 pathway through suppressing TGF-β1 activation and secretion in vivo. Our findings suggest that hydrogen is important for preventing and treating AngII-mediated AF and atrial fibrosis, suggesting that hydrogen could be used as the candidate way to prevent and treat AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Clinical Lab, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Cardiology, Nangang Branch of Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China.
- Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
ORCID-Profile: Jiaren Liu, Wei Yang
Förderung
- Research Projects of Fourth Affiliated Hospital of Harbin Medical University
Zitieren
APA
Zhang, B., Hou, J., Liu, J., He, J., Gao, Y., Li, G., Ma, T., Lv, X., Dong, L., & Yang, W. (2025). RETRACTED: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways. PLOS ONE, 20(1), e0310852. https://doi.org/10.1371/journal.pone.0310852
Vancouver
Zhang B, Hou J, Liu J, He J, Gao Y, Li G, et al. RETRACTED: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways. PLOS ONE. 2025;20(1):e0310852. doi:10.1371/journal.pone.0310852
BibTeX
@article{Zhang2025,
author = {Zhang, Binmei and Hou, Jingxiu and Liu, Jiaren and He, Junhui and Gao, Yunan and Li, Guangnan and Ma, Tianjiao and Lv, Xin and Dong, Li and Yang, Wei},
title = {RETRACTED: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0310852},
doi = {10.1371/journal.pone.0310852}
}
EUVIMED